Atlas FDA

Progensa PCA3 Assay

FDA premarket approval P100033/S012 · decided 2020-07-21

Approval details

PMA number
P100033
Supplement
S012
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Progensa PCA3 Assay
Generic name
Prostrate cancer genes nucleic acid amplification test system
Applicant
Gen-Probe Incorporated
Date received
2020-07-09
Decision date
2020-07-21
Days to decision
12 days
Decision code
OK30
Product code
OYM
Advisory committee
Pathology
Expedited review
No
Location
San Diego, CA
Statement
Use of a new reusable shipping container for shipping refrigerated products.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
APTIMA TRICHOMONAS VAGINALIS ASSAY (DEN110012)Gen-Probe Incorporated2011-04-19